Abstract
Membranoproliferative glomerulonephritis (MPGN) is a distinctive form of chronic glomerulonephritis. We present the results of our 96 paediatric patients with MPGN, reporting the survival and factors affecting prognosis in these patients. There were 64 boys and 32 girls with an age range of 2–17 (mean 10.6±3.7) years. All patients initially received oral corticosteroid therapy; remission was achieved in 22.9%. The unresponsive 77.1% either received cyclophosphamide and/or pulse methylprednisolone; 25.4% and 50.0% of these patients entered complete remission, respectively. The overall 1-year renal survivals of the MPGN patients were 90.1%, 5-year and 10-year survival rates were 81.9% and 61%, respectively. At multivariate analysis the factors affecting renal prognosis were haematuria at presentation (p<0.05, risk factor 3.52), urinary protein/creatinine ratio (p<0.05, risk factor 1.06 per 1 unit) and low haemoglobin values (p<0.05, risk factor 1.43 for each 1 g/dl decrement). We suggest that more aggressive immunosuppressive therapy should be instituted in patients unresponsive to steroids and that the aforementioned risk factors are higher for the development of renal failure.
Similar content being viewed by others
References
Chesney, R. W., Novello, A. C.: Forms of nephrotic syndrome more likely to progress to renal impairment.Pediatr. Clin. North Am., 34, 609 (1987).
Faedda, R., Satta, A., Tanda, F., Pirisi, M., Bartoli, E.: Immunosuppressive treatment of membranoproliferative glomerulonephritis.Nephron, 67, 59 (1994).
Cameron, J. S., Turner, D. R., Heaton, J. et al.: Idiopathic mesangiocapillary glomerulonephritis: Comparison of types I and II in children and adults and long term prognosis.Am. J. Med., 74, 175 (1983).
Habib, R., Kleinknecht, C., Gubler, M. C. et al.: Idiopathic membranoproliferative glomerulonephritis in children. Reports of 105 cases.Clin. Nephrol., 1, 194 (1973).
Davis, A. E., Schneeberger, E. E., Grupe, W. E., Mc Cluskey, R. T.: Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease in children (DDD).Clin. Nephrol., 9, 184 (1978).
D'Amico, G.: Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature.Am. J. Kidney Dis., 20, (4), 315 (1992).
Tarshish, P., Bernstein, J., Tobin, J. N., Edelmann, C. M. Jr.: Treatment of mesangiocapillary glomerulonephritis with alternate-day-prednisone. A report of The International Study of Kidney Disease in Children.Pediatr. Nephrol., 6, 123 (1992).
Kincaid-Smith, P.: The natural history and treatment of mesangiocapillary glomerulonephritis. In: Kincaid-Smith, P., Mathew, T. H., Becker, E. L. (eds): Glomerulonephritis, Wiley, New York 1973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arslan, S., Saatci, U., Ozen, S. et al. Membranoproliferative glomerulonephritis in childhood: Factors affecting prognosis. International Urology and Nephrology 29, 711–716 (1997). https://doi.org/10.1007/BF02552190
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02552190